天坛生物,600161,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,521,-- ,-- ,--,--% 血液制品,154960,-- ,-- ,--,--% 天坛生物,600161,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),813,92,721,88.64%,0.44% 血液制品,327373,164481,162892,49.76%,99.56% 天坛生物,600161,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),203,7,196,96.59%,0.14% 血液制品,292903,154816,138086,47.14%,99.86% 天坛生物,600161,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品分部,122029,-- ,-- ,--,--% 天坛生物,600161,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,151314,68147,83167,54.96%,84.25% 预防制品,24553,9435,15119,61.57%,15.31% 其他(补充),649,215,434,66.9%,0.44% 天坛生物,600161,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,69301,-- ,-- ,--,--% 预防制品,25116,-- ,-- ,--,--% 天坛生物,600161,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1953,514,1439,73.69%,1.29% 血液制品,129369,59006,70363,54.39%,63.06% 预防制品,78251,38479,39772,50.83%,35.65% 天坛生物,600161,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),976,238,737,75.57%,1.77% 血液制品,60535,29586,30949,51.13%,74.15% 预防制品,26547,16495,10051,37.86%,24.08% 天坛生物,600161,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2169,1250,919,42.38%,1.17% 血液制品,100061,52586,47475,47.45%,60.38% 预防制品,59569,29334,30235,50.76%,38.45% 天坛生物,600161,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 预防制品,34351,14783,19568,56.96%,47.37% 其他(补充),940,596,344,36.61%,0.83% 血液制品,47123,25726,21397,45.41%,51.8% 天坛生物,600161,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 预防制品,84065,22759,61306,72.93%,58.35% 血液制品,95344,53321,42023,44.08%,40% 其他(补充),3246,1506,1740,53.6%,1.66% 天坛生物,600161,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2584,-- ,-- ,--,0% 血液制品,54218,31098,23120,42.64%,38.09% 预防制品,51527,13942,37585,72.94%,61.91% 天坛生物,600161,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1401,1144,257,18.33%,0.25% 血液制品,91116,51665,39451,43.3%,37.8% 预防制品,91134,26470,64664,70.96%,61.96% 天坛生物,600161,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),710,-- ,-- ,--,0% 血液制品,44965,24569,20397,45.36%,38.61% 预防制品,44459,12025,32434,72.95%,61.39% 天坛生物,600161,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2140,-- ,-- ,--,0% 血液制品,56709,27432,29277,51.63%,32.78% 预防制品,91386,31349,60037,65.7%,67.22% 天坛生物,600161,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:关联交易,376,-- ,-- ,--,0% 血液制品,30981,14027,16954,54.72%,38.5% 预防制品,40547,13467,27080,66.79%,61.5% 其他(补充),1377,-- ,-- ,--,0% 天坛生物,600161,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1550,-- ,-- ,--,0% 血液制品,65080,27179,37901,58.24%,44.58% 预防制品,72810,25691,47118,64.71%,55.42% 天坛生物,600161,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),303,-- ,-- ,--,0% 血液制品,33210,13555,19655,59.18%,55.53% 预防制品,23911,8174,15738,65.82%,44.47% 天坛生物,600161,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,47329,19939,27389,57.87%,39.66% 预防制品,71075,29397,41678,58.64%,60.34% 天坛生物,600161,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,26015,11629,14386,55.3%,42.89% 预防制品,30734,11578,19156,62.33%,57.11% 天坛生物,600161,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,35072,16868,18204,51.9%,26.61% 预防制品,72571,22356,50215,69.19%,73.39% 天坛生物,600161,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,2141,1807,334,15.6%,1.35% 预防制品,34544,10222,24322,70.41%,98.65% 天坛生物,600161,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,7028,5419,1609,22.89%,3.67% 预防制品,60243,18027,42216,70.08%,96.33% 天坛生物,600161,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,5205,3953,1252,24.05%,6.37% 预防制品,26327,7938,18388,69.85%,93.63% 天坛生物,600161,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,9089,6768,2321,25.54%,7.04% 预防制品,43379,12748,30631,70.61%,92.96% 天坛生物,600161,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,236,181,56,23.54%,0.36% 血液制品,2337,1689,649,27.75%,4.22% 预防制品(疫苗),19936,5281,14654,73.51%,95.41% 天坛生物,600161,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 销售商品,41378,15969,25409,61.41%,100% 天坛生物,600161,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血制品类,5417,4153,1264,23.33%,6.48% 疫苗类,24659,6436,18223,73.9%,93.52% 天坛生物,600161,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血制品类,3668,2951,718,19.56%,5.07% 疫苗类,17906,4469,13437,75.04%,94.93% 天坛生物,600161,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,1247,846,401,32.17%,7.62% 预防制品,6857,1996,4860,70.88%,92.38% 天坛生物,600161,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,2,1,1,36.18%,0% 血液制品,5693,4730,963,16.92%,5.03% 预防制品(疫苗),28641,10472,18169,63.44%,94.96% 天坛生物,600161,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液类产品,3888,3238,650,16.72%,4.29% 疫苗类产品,22554,8052,14502,64.3%,95.71% 天坛生物,600161,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血制品类,2827,2334,493,17.43%,4.44% 疫苗类,16671,6075,10595,63.56%,95.56% 天坛生物,600161,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血制品类,961,799,163,16.91%,3.98% 疫苗类,6332,2412,3920,61.91%,96.02% 天坛生物,600161,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液类产品,2828,2549,279,9.87%,2.42% 疫苗类产品,18248,7014,11235,61.56%,97.58% 天坛生物,600161,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液类产品,1906,1706,200,10.51%,2.43% 疫苗类产品,12898,4843,8055,62.45%,97.57% 天坛生物,600161,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 疫苗类产品,5526,2211,3315,59.98%,100% 天坛生物,600161,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,4965,2529,2437,49.07%,19.89% 糖丸,1833,792,1040,56.77%,8.49% 冻于风疹疫苗,2037,407,1630,80.01%,13.31% 人血白蛋白,4011,4374,-364,-9.07%,-2.97% 基因乙肝疫苗,11646,4141,7505,64.44%,61.28% 天坛生物,600161,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液类产品,3253,3162,90,2.78%,1.03% 疫苗类产品,14121,5392,8729,61.82%,98.97% 天坛生物,600161,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,3266,1599,1666,51.03%,25.3% 人血白蛋白,2140,2431,-291,-13.62%,-4.42% 基因乙肝疫苗,6730,2330,4399,65.37%,66.79% 冻于风疹疫苗,995,183,812,81.61%,12.33% 天坛生物,600161,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,140,63,77,55.16%,2.78% 菌苗类产品,60,36,24,40.1%,0.86% 血液类产品,250,278,-28,-11.11%,-1% 疫苗类产品,3988,1280,2708,67.9%,97.36% 天坛生物,600161,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 人血白蛋白,2021,2950,-928,-45.93%,-9.64% 冻干风疹疫苗,3415,568,2847,83.37%,29.56% 基因乙肝疫苗,11123,3411,7712,69.34%,80.08% 天坛生物,600161,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,457,415,43,9.3%,0.75% 血液制品,979,1538,-559,-57.1%,-9.86% 菌苗,163,92,72,43.89%,1.26% 疫苗,8693,2578,6115,70.34%,107.84%